Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Sep 16, 2024
Open Peer Review Period: Sep 16, 2024 - Nov 11, 2024
Date Accepted: Mar 20, 2025
(closed for review but you can still tweet)
Diagnosis test accuracy of artificial intelligence for endometrial cancer: A systematic review and meta-analysis
ABSTRACT
Background:
Endometrial cancer is one of the most common gynecological tumors, and early screening and diagnosis are crucial for its treatment. Research on the application of artificial intelligence in the diagnosis of endometrial cancer is increasing, but there is currently no comprehensive meta-analysis to evaluate the diagnostic accuracy (DTA) of artificial intelligence in screening for endometrial cancer.
Objective:
A systematic review of AI-based endometrial cancer screening is needed to clarify its diagnostic accuracy (DTA) and provide evidence for the application of AI technology in screening for endometrial cancer.
Methods:
A search was conducted across PubMed, EMBASE, Cochrane Library, Web of Science, and Scopus databases to include studies published in English that evaluated the performance of AI in endometrial cancer screening. Two independent reviewers screened the titles and abstracts, and the quality of the selected studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. The certainty of the diagnostic test evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.
Results:
A total of 13 studies were included, and the hierarchical summary receiver operating characteristic model used for the meta-analysis showed that the overall sensitivity of AI-based endometrial cancer screening was 86% (95% CI: 79-90%) and specificity was 92% (95% CI: 87-95%). Subgroup analysis revealed similar results across AI type, study region, publication year, and study type, but the overall quality of evidence was low.
Conclusions:
AI-based endometrial cancer screening can effectively detect patients with endometrial cancer, but large-scale population studies are needed in the future to further clarify the diagnostic accuracy (DTA) of AI in screening for endometrial cancer.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.